Branded formulations drive Eris Lifesciences' Q2 PAT up by 10% to Rs 118 cr
Revenue from operations grow 9% YoY to Rs 360 crore
Revenue from operations grow 9% YoY to Rs 360 crore https://ift.tt/3bpyXJH October 29, 2021 at 12:43AM
Revenue from operations grow 9% YoY to Rs 360 crore https://ift.tt/3bpyXJH October 29, 2021 at 12:43AM
Comments
Post a Comment